ID | 401 |
No | 401 |
Brand Name | ABEVMY 400 |
Ingredients | BEVACIZUMAB (R-DNA ) 400 MG/16 ML |
Dosage Form | SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | STORE AT TEMPERATURE BETWEEN 2 - 8 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 1 VIAL X 16 ML |
Dispensing Category | Prescription only |
ATC Classification | L01XC07 |
Pharmaceutical Class | ANTINEOPLASTICS |
Indications | TREATMENT OF ADULT PATIENTS WITH METASTATIC CARCINOMA OF TH E COLON OR RECTUM (IN COMBINATION WITH FLUOROPYRIMIDINE BASED CHEMOTHERAPY) |
Contraindications | HYPERSENSITIVITY TO API OR EXCIPIENT, CHINESE HAMSTER OVARY CELL PRODUCT, PREGNANCY |
Side Effects | GASTROINJTESTINAL PERFORATIONS AND FISTULAE, WOUD HEALING COMPLICATION, HAEMORRHAGE, ARTERIAL THROMBOEMBOLISM, HYPERTENTION, PROTEINURIA, OVARIAN FAILURE, POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
Unit Price | |
EDL |
Yes |
Description | CLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN LIQUID |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | BIOCON LIMITED |
Country | INDIA |
Import Registration No | KTK/28D/7/2006 |
Import Registration Date | 2006-04-28 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2020-11-27 |
FDD Registration No | 08 I 5269/22 |
FDD Registration Date | 2022-08-26 |
Expiry Date | 2025-08-25 |